Menu

About Us Industry Report Services Press Release Careers Contact Us

Amino Acid Metabolism Disorders Treatment Market, by Product (Folic Acid, Vitamin B6 and B12, Arginine, Thiamine, Vitamin D, Betaine, Carglumic acid, Sapropterin dihydrochloride), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), Indication (Phenylketonuria, Maple Syrup Urine Disease, Citrullinemia, Homocystinuria; Argininosuccinic Acidemia): Global Opportunity Analysis and Industry Forecast, 2020-2027

LI2010854

Pages: 139

Jan 2023

The global amino acid metabolism disorders treatment market is estimated to surpass $1,489.4 million by 2027, exhibiting a CAGR of 7.3% from 2020 to 2027.

The report provides all-inclusive analysis of global amino acid metabolism disorders treatment market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global amino acid metabolism disorders treatment market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global amino acid metabolism disorders treatment market.

In addition, the report provides market size and forecast scrutinizing global amino acid metabolism disorders treatment market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global amino acid metabolism disorders treatment market. In the report, the global amino acid metabolism disorders treatment market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover amino acid metabolism disorders treatment market landscape in respective regions.

Furthermore, competitive scenario of the global amino acid metabolism disorders treatment market is covered in the report. Major players functioning in the global amino acid metabolism disorders treatment market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global amino acid metabolism disorders treatment market, and others.

RESEARCH METHODOLOGY

The research report is drafted by in-house research analysts who sincerely examine the market scenario and form predictions. The market forecasts specified in the report have been derived using proven research approaches and analytical models & tools. The use of such pioneering and effective tools helps market analysts in analyzing, filtering, and providing highly precise statistics and estimates. The report provides an extensive research and analysis backed with factual data obtained from various interviews with market players, reliable and renowned sources of data, and regional intelligence. The insights provided in the report can help investors, stakeholders, and market players to understand investment suitability and seize opportunities for advancements, investments, and partnerships in the global amino acid metabolism disorders treatment market.

The research report is formulated by collecting different information, news, and statistics about the amino acid metabolism disorders treatment market. For instance, detailed interviews and discussions with veteran market players and stakeholders, including upstream and downstream members have been conducted to obtain reliable and realistic data. Even though primary research forms the crucial part of the research report, secondary research plays a significant role in backing the research outcomes.  Nearly 5,900 product type literatures, business magazines, company annual reports, and other such significant documents of leading market players have been considered and studied for thorough understanding of the market scenario. In addition, truthful industry bulletins, medical newsletters, trade associations’ journals, and government websites have been explored for tracking down high-value market insights.

KEY MARKET BENEFITS

  • The report provides the market size and predictions for the period from 2019 to 2027
  • This report delivers inventions, trends, and innovative developments along with an exhaustive quantitative analysis of the amino acid metabolism disorders treatment market during the period of forecast
  • The prevailing and forthcoming investment opportunities along with the strategic assessment of the global amino acid metabolism disorders treatment market growth is delivered
  • The market size and forecasts are derived by scrutinizing market boomers and restraints, and key developments in the amino acid metabolism disorders treatment market
  • Insights into foremost market players, Porter’s Five Analysis, and top winning business strategies is provided
  • Growth tactics and initiatives taken by the top market players are outlined to understand the competitive scenario and strength of the market

KEY MARKET SEGMENTS

The report segments the global market into product ,distribution channel ,indication and region.

  • Product: Folic Acid, Vitamin B6 and B12, Arginine, Thiamine, Vitamin D, Betaine, Carglumic acid, Sapropterin dihydrochloride
  • Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores
  • Indication: Phenylketonuria, Maple Syrup Urine Disease, Citrullinemia, Homocystinuria; Argininosuccinic Acidemia

Regionally, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA.

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of LAMEA

KEY MARKET PLAYERS

The global amino acid metabolism disorders treatment market is consolidated with the presence of large number of key players. These players are increasingly focusing on innovation, geographical expansion of product portfolios, and novel developments to obtain a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Players in global amino acid metabolism disorders treatment market include:

    1. GlaxoSmithKline PLC

    2. Pfizer, Inc.

    3. AMINO GmbH

    4. Merck KGaA

    5. Recordati S.p.A.

    6. Koninklijke DSM N.V.

    7. Sanofi

    8. Shine Star (Hubei) Biological Engineering Co., Ltd.

    9. KYOWA HAKKO BIO CO., LTD.

    10. Civentichem, LLC, Ltd.

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Amino Acid Metabolism Disorders Treatment Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Amino Acid Metabolism Disorders Treatment Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Amino Acid Metabolism Disorders Treatment Market, By Technology

    • 5.1. Overview

    • 5.2 Folic Acid

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Vitamin B6 and B12

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Arginine

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Thiamine

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 Vitamin D

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Betaine

      • 5.7.1 Definition, key trends, growth factors, and opportunities

      • 5.7.2 Market size analysis, by region, 2020-2027

      • 5.7.3 Market share analysis, by country, 2020-2027

    • 5.8 Carglumic acid

      • 5.8.1 Definition, key trends, growth factors, and opportunities

      • 5.8.2 Market size analysis, by region, 2020-2027

      • 5.8.3 Market share analysis, by country, 2020-2027

    • 5.9 Sapropterin dihydrochloride

      • 5.9.1 Definition, key trends, growth factors, and opportunities

      • 5.9.2 Market size analysis, by region, 2020-2027

      • 5.9.3 Market share analysis, by country, 2020-2027

    • 5.10 Research Dive Exclusive Insights

      • 5.10.1 Market attractiveness

      • 5.10.2 Competition heatmap

  • 6. Amino Acid Metabolism Disorders Treatment Market, By Target Area

    • 6.1. Overview

    • 6.2 Hospital Pharmacies

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Retail Pharmacies

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Online Stores

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Research Dive Exclusive Insights

      • 6.5.1 Market attractiveness

      • 6.5.2 Competition heatmap

  • 7. Amino Acid Metabolism Disorders Treatment Market, By Treatment

    • 7.1. Overview

    • 7.2 Phenylketonuria

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Maple Syrup Urine Disease

      • 7.3.1 Definition, key trends, growth factors, and opportunities

      • 7.3.2 Market size analysis, by region, 2020-2027

      • 7.3.3 Market share analysis, by country, 2020-2027

    • 7.4 Citrullinemia

      • 7.4.1 Definition, key trends, growth factors, and opportunities

      • 7.4.2 Market size analysis, by region, 2020-2027

      • 7.4.3 Market share analysis, by country, 2020-2027

    • 7.5 Homocystinuria; Argininosuccinic Acidemia

      • 7.5.1 Definition, key trends, growth factors, and opportunities

      • 7.5.2 Market size analysis, by region, 2020-2027

      • 7.5.3 Market share analysis, by country, 2020-2027

    • 7.6 Research Dive Exclusive Insights

      • 7.6.1 Market attractiveness

      • 7.6.2 Competition heatmap

  • 8. Amino Acid Metabolism Disorders Treatment Market, By Region

    • 8.1 North America

      • 8.1.1 U.S

        • 8.1.1.1 Market size analysis, By Technology, 2020-2027

        • 8.1.1.2 Market size analysis, By Target Area, 2020-2027

        • 8.1.1.3 Market size analysis, By Treatment, 2020-2027

      • 8.1.2 Canada

        • 8.1.2.1 Market size analysis, By Technology, 2020-2027

        • 8.1.2.2 Market size analysis, By Target Area, 2020-2027

        • 8.1.2.3 Market size analysis, By Treatment, 2020-2027

      • 8.1.3 Mexico

        • 8.1.3.1 Market size analysis, By Technology, 2020-2027

        • 8.1.3.2 Market size analysis, By Target Area, 2020-2027

        • 8.1.3.3 Market size analysis, By Treatment, 2020-2027

      • 8.1.4 Research Dive Exclusive Insights

        • 8.1.4.1 Market attractiveness

        • 8.1.4.2 Competition heatmap

    • 8.2 Europe

      • 8.2.1 Germany

        • 8.2.1.1 Market size analysis, By Technology, 2020-2027

        • 8.2.1.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.1.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.2 UK

        • 8.2.2.1 Market size analysis, By Technology, 2020-2027

        • 8.2.2.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.2.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.3 France

        • 8.2.3.1 Market size analysis, By Technology, 2020-2027

        • 8.2.3.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.3.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.4 Spain

        • 8.2.4.1 Market size analysis, By Technology, 2020-2027

        • 8.2.4.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.4.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.5 Italy

        • 8.2.5.1 Market size analysis, By Technology, 2020-2027

        • 8.2.5.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.5.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.6 Rest of Europe

        • 8.2.6.1 Market size analysis, By Technology, 2020-2027

        • 8.2.6.2 Market size analysis, By Target Area, 2020-2027

        • 8.2.6.3 Market size analysis, By Treatment, 2020-2027

      • 8.2.7 Research Dive Exclusive Insights

        • 8.2.7.1 Market attractiveness

        • 8.2.7.2 Competition heatmap

    • 8.3 Asia-Pacific

      • 8.3.1 China

        • 8.3.1.1 Market size analysis, By Technology, 2020-2027

        • 8.3.1.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.1.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.2 Japan

        • 8.3.2.1 Market size analysis, By Technology, 2020-2027

        • 8.3.2.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.2.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.3 India

        • 8.3.3.1 Market size analysis, By Technology, 2020-2027

        • 8.3.3.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.3.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.4 Australia

        • 8.3.4.1 Market size analysis, By Technology, 2020-2027

        • 8.3.4.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.4.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.5 South Korea

        • 8.3.5.1 Market size analysis, By Technology, 2020-2027

        • 8.3.5.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.5.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.6 Rest of Asia-Pacific

        • 8.3.6.1 Market size analysis, By Technology, 2020-2027

        • 8.3.6.2 Market size analysis, By Target Area, 2020-2027

        • 8.3.6.3 Market size analysis, By Treatment, 2020-2027

      • 8.3.7 Research Dive Exclusive Insights

        • 8.3.7.1 Market attractiveness

        • 8.3.7.2 Competition heatmap

    • 8.4 LAMEA

      • 8.4.1 Brazil

        • 8.4.1.1 Market size analysis, By Technology, 2020-2027

        • 8.4.1.2 Market size analysis, By Target Area, 2020-2027

        • 8.4.1.3 Market size analysis, By Treatment, 2020-2027

      • 8.4.2 Saudi Arabia

        • 8.4.2.1 Market size analysis, By Technology, 2020-2027

        • 8.4.2.2 Market size analysis, By Target Area, 2020-2027

        • 8.4.2.3 Market size analysis, By Treatment, 2020-2027

      • 8.4.3 UAE

        • 8.4.3.1 Market size analysis, By Technology, 2020-2027

        • 8.4.3.2 Market size analysis, By Target Area, 2020-2027

        • 8.4.3.3 Market size analysis, By Treatment, 2020-2027

      • 8.4.4 South Africa

        • 8.4.4.1 Market size analysis, By Technology, 2020-2027

        • 8.4.4.2 Market size analysis, By Target Area, 2020-2027

        • 8.4.4.3 Market size analysis, By Treatment, 2020-2027

      • 8.4.5 Rest of LAMEA

        • 8.4.5.1 Market size analysis, By Technology, 2020-2027

        • 8.4.5.2 Market size analysis, By Target Area, 2020-2027

        • 8.4.5.3 Market size analysis, By Treatment, 2020-2027

      • 8.4.6 Research Dive Exclusive Insights

        • 8.4.6.1 Market attractiveness

        • 8.4.6.2 Competition heatmap

  • 9. Competitive Landscape

    • 9.1 Top winning strategies, 2020-2027

      • 9.1.1 By strategy

      • 9.1.2 By year

    • 9.2 Strategic overview

    • 9.3 Market share analysis, 2020-2027

  • 10. Company Profiles

    • 10.1 GlaxoSmithKline PLC

      • 10.1.1 Overview

      • 10.1.2 Business segments

      • 10.1.3 Product portfolio

      • 10.1.4 Financial performance

      • 10.1.5 Recent developments

      • 10.1.6 SWOT analysis

    • 10.2 Pfizer, Inc.

      • 10.2.1 Overview

      • 10.2.2 Business segments

      • 10.2.3 Product portfolio

      • 10.2.4 Financial performance

      • 10.2.5 Recent developments

      • 10.2.6 SWOT analysis

    • 10.3 AMINO GmbH

      • 10.3.1 Overview

      • 10.3.2 Business segments

      • 10.3.3 Product portfolio

      • 10.3.4 Financial performance

      • 10.3.5 Recent developments

      • 10.3.6 SWOT analysis

    • 10.4 Merck KGaA

      • 10.4.1 Overview

      • 10.4.2 Business segments

      • 10.4.3 Product portfolio

      • 10.4.4 Financial performance

      • 10.4.5 Recent developments

      • 10.4.6 SWOT analysis

    • 10.5 Recordati S.p.A.

      • 10.5.1 Overview

      • 10.5.2 Business segments

      • 10.5.3 Product portfolio

      • 10.5.4 Financial performance

      • 10.5.5 Recent developments

      • 10.5.6 SWOT analysis

    • 10.6 Koninklijke DSM N.V.

      • 10.6.1 Overview

      • 10.6.2 Business segments

      • 10.6.3 Product portfolio

      • 10.6.4 Financial performance

      • 10.6.5 Recent developments

      • 10.6.6 SWOT analysis

    • 10.7 Sanofi

      • 10.7.1 Overview

      • 10.7.2 Business segments

      • 10.7.3 Product portfolio

      • 10.7.4 Financial performance

      • 10.7.5 Recent developments

      • 10.7.6 SWOT analysis

    • 10.8 Shine Star (Hubei) Biological Engineering Co., Ltd.

      • 10.8.1 Overview

      • 10.8.2 Business segments

      • 10.8.3 Product portfolio

      • 10.8.4 Financial performance

      • 10.8.5 Recent developments

      • 10.8.6 SWOT analysis

    • 10.9 KYOWA HAKKO BIO CO., LTD.

      • 10.9.1 Overview

      • 10.9.2 Business segments

      • 10.9.3 Product portfolio

      • 10.9.4 Financial performance

      • 10.9.5 Recent developments

      • 10.9.6 SWOT analysis

    • 10.10 Civentichem, LLC, Ltd.

      • 10.10.1 Overview

      • 10.10.2 Business segments

      • 10.10.3 Product portfolio

      • 10.10.4 Financial performance

      • 10.10.5 Recent developments

      • 10.10.6 SWOT analysis

Purchase Full Report of
Amino Acid Metabolism Disorders Treatment Market

PURCHASE OPTIONS

  

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Enquire To Buy

Need to add more ?

Request Customization

Customers Also Viewed